SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-007781
Filing Date
2020-05-06
Accepted
2020-05-06 08:06:23
Documents
82
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 594509
2 ex10-1.htm EX-10.1 305184
3 ex10-1_001.jpg GRAPHIC 14890
4 ex10-2.htm EX-10.2 88371
5 ex10-2_001.jpg GRAPHIC 16754
6 ex10-3.htm EX-10.3 39885
7 ex10-3_001.jpg GRAPHIC 38415
8 ex10-4.htm EX-10.4 21685
9 ex31-1.htm EX-31.1 16402
10 ex31-2.htm EX-31.2 16586
11 ex32-1.htm EX-32.1 5753
12 ex32-2.htm EX-32.2 5904
  Complete submission text file 0001493152-20-007781.txt   3914344

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE vbiv-20200331.xml EX-101.INS 468798
14 XBRL SCHEMA FILE vbiv-20200331.xsd EX-101.SCH 66447
15 XBRL CALCULATION FILE vbiv-20200331_cal.xml EX-101.CAL 63001
16 XBRL DEFINITION FILE vbiv-20200331_def.xml EX-101.DEF 156740
17 XBRL LABEL FILE vbiv-20200331_lab.xml EX-101.LAB 352835
18 XBRL PRESENTATION FILE vbiv-20200331_pre.xml EX-101.PRE 246369
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 20851206
SIC: 2834 Pharmaceutical Preparations